3/4
11:48 am
nuvb
Nuvation Bio (NUVB) Generates $62.9M Annual Revenue Following Successful Erozi Launch [Yahoo! Finance]
Medium
Report
Nuvation Bio (NUVB) Generates $62.9M Annual Revenue Following Successful Erozi Launch [Yahoo! Finance]
3/4
08:30 am
nuvb
Nuvation Bio Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Medium
Report
Nuvation Bio Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
3/4
07:35 am
nuvb
Nuvation Bio Transitions To Commercial Stage With Iptrozi And Safusidenib Progress [Yahoo! Finance]
Medium
Report
Nuvation Bio Transitions To Commercial Stage With Iptrozi And Safusidenib Progress [Yahoo! Finance]
3/3
04:09 pm
nuvb
Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy [Yahoo! Finance]
Medium
Report
Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy [Yahoo! Finance]
3/3
02:22 pm
nuvb
Nuvation Bio (NUVB) had its price target lowered by UBS Group AG from $10.00 to $7.00. They now have a "neutral" rating on the stock.
Low
Report
Nuvation Bio (NUVB) had its price target lowered by UBS Group AG from $10.00 to $7.00. They now have a "neutral" rating on the stock.
3/3
10:46 am
nuvb
Nuvation Bio (NUVB) had its price target raised by Royal Bank Of Canada from $12.00 to $13.00. They now have an "outperform" rating on the stock.
Medium
Report
Nuvation Bio (NUVB) had its price target raised by Royal Bank Of Canada from $12.00 to $13.00. They now have an "outperform" rating on the stock.
3/3
02:42 am
nuvb
Nuvation Bio outlines first-line IBTROZI growth strategy with 50-month median DOR amid expanding global partnerships [Seeking Alpha]
High
Report
Nuvation Bio outlines first-line IBTROZI growth strategy with 50-month median DOR amid expanding global partnerships [Seeking Alpha]
3/3
02:42 am
nuvb
Nuvation Bio Inc. (NUVB) Q4 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Nuvation Bio Inc. (NUVB) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/3
12:59 am
nuvb
Nuvation Bio (NUVB) Q4 2025 Earnings Transcript [Yahoo! Finance]
High
Report
Nuvation Bio (NUVB) Q4 2025 Earnings Transcript [Yahoo! Finance]
3/3
12:03 am
nuvb
Nuvation Bio Inc (NUVB) Q4 2025 Earnings Call Highlights: Strong Market Acceptance of Erozi ... [Yahoo! Finance]
High
Report
Nuvation Bio Inc (NUVB) Q4 2025 Earnings Call Highlights: Strong Market Acceptance of Erozi ... [Yahoo! Finance]
3/2
08:21 pm
nuvb
Nuvation Bio Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Nuvation Bio Q4 Earnings Call Highlights [Yahoo! Finance]
3/2
04:22 pm
nuvb
Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/2
04:21 pm
nuvb
Nuvation Bio GAAP EPS of -$0.11 misses by $0.02, revenue of $41.9M beats by $4.4M [Seeking Alpha]
High
Report
Nuvation Bio GAAP EPS of -$0.11 misses by $0.02, revenue of $41.9M beats by $4.4M [Seeking Alpha]
3/2
04:05 pm
nuvb
Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
High
Report
Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
3/2
03:12 am
nuvb
Nuvation Bio Inc. (NUVB) Amends Protocol on Safusidenib Trials in Astrocytoma [Yahoo! Finance]
Low
Report
Nuvation Bio Inc. (NUVB) Amends Protocol on Safusidenib Trials in Astrocytoma [Yahoo! Finance]
2/28
08:33 am
nuvb
Nuvation Bio (NUVB) Is Up 8.6% After Expanding Safusidenib Into Phase 3 Registrational Trial - Has The Bull Case Changed? [Yahoo! Finance]
Low
Report
Nuvation Bio (NUVB) Is Up 8.6% After Expanding Safusidenib Into Phase 3 Registrational Trial - Has The Bull Case Changed? [Yahoo! Finance]
2/27
07:03 pm
nuvb
Nuvation Bio Inc (NUVB) Q4 2025 Earnings Report Preview: What To Expect [Yahoo! Finance]
Low
Report
Nuvation Bio Inc (NUVB) Q4 2025 Earnings Report Preview: What To Expect [Yahoo! Finance]
2/27
12:13 am
nuvb
Where is Nuvation Bio Inc. (NUVB) Headed According to Wall Street Analysts? [Yahoo! Finance]
Medium
Report
Where is Nuvation Bio Inc. (NUVB) Headed According to Wall Street Analysts? [Yahoo! Finance]
2/25
04:24 pm
nuvb
Nuvation Bio to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Nuvation Bio to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/25
04:05 pm
nuvb
Nuvation Bio to Participate in Upcoming Investor Conferences
Medium
Report
Nuvation Bio to Participate in Upcoming Investor Conferences
2/17
04:25 pm
nuvb
Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026 [Yahoo! Finance]
Low
Report
Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026 [Yahoo! Finance]
2/17
04:05 pm
nuvb
Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026
Low
Report
Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026
2/10
09:41 am
nuvb
Nuvation Bio (NYSE:NUVB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Low
Report
Nuvation Bio (NYSE:NUVB) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
2/9
08:00 am
nuvb
Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma
Medium
Report
Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma
2/2
12:53 am
nuvb
Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy [Seeking Alpha]
Medium
Report
Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy [Seeking Alpha]